Bioxcel therapeutics, inc. deadline approaching: kessler topaz meltzer & check, llp reminds investors of bioxcel therapeutics, inc. of deadline in securities fraud class action lawsuit

Radnor, pa. , aug. 8, 2023 /prnewswire/ -- the law firm of kessler topaz meltzer & check, llp (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the united states district court for the district of connecticut against bioxcel therapeutics, inc. ("bioxcel") (nasdaq: btai).
BTAI Ratings Summary
BTAI Quant Ranking